Literature DB >> 7437992

Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone.

M I Khan.   

Abstract

Combination therapy with a loop diuretic and an aldosterone antagonist can produce normokalemic hypochloremic alkalosis, a complication not previously documented in the literature. This report describes 74 patients who had severe congestive heart failure treated with a combination of furosemide and spironolactone in whom this complication developed. Acetazolamide corrected the metabolic abnormality. The combination of furosemide and spironolactone with intermittent courses of acetazolamide was very effective in the treatment of severe congestive heart failure complicated by normokalemic hypochloremic alkalosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437992      PMCID: PMC1704901     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  27 in total

1.  BODY AND SERUM POTASSIUM IN LIVER DISEASE. I. RELATIONSHIP TO HEPATIC FUNCTION AND ASSOCIATED FACTORS.

Authors:  T H CASEY; W H SUMMERSKILL; A L ORVIS
Journal:  Gastroenterology       Date:  1965-02       Impact factor: 22.682

2.  Management of congestive heart failure; management designed to avoid serious disturbances of electrolyte and water balance.

Authors:  D W SELDIN
Journal:  AMA Arch Intern Med       Date:  1955-03

3.  Effect of high K, and low K quinindine on QRS duration and ventricular action potential.

Authors:  L S GETTES; B SURAWICZ; J C SHIUE
Journal:  Am J Physiol       Date:  1962-12

4.  Mechanisms contributing to unresponsiveness to mecurial diuretics in congestive failure.

Authors:  R E WESTON; D J W ESCHER; J GROSSMAN; L LEITER
Journal:  J Clin Invest       Date:  1952-10       Impact factor: 14.808

5.  The effect of intravenously administered 6063, the carbonic anhydrase inhibitor, 2-acetylamino-1, 3, 4-thiadiazole-5-sulfonamide, on fluid and electrolytes in normal subjects and patients with congestive heart failure.

Authors:  C K FRIEDBERG; M HALPERN; R TAYMOR
Journal:  J Clin Invest       Date:  1952-12       Impact factor: 14.808

6.  The effect of changes in concentration of cations on the electrocardiogram of the isolated perfused heart.

Authors:  W A BUTCHER; K G WAKIM; H E ESSEX; R D PRUITT; H B BURCHELL
Journal:  Am Heart J       Date:  1952-06       Impact factor: 4.749

7.  Diuretics and potassium metabolism: a reassessment of the need, effectiveness and safety of potassium therapy.

Authors:  J P Kassirer; J T Harrington
Journal:  Kidney Int       Date:  1977-06       Impact factor: 10.612

8.  Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  JAMA       Date:  1973-07-02       Impact factor: 56.272

9.  Aldosterone antagonists and triamterene.

Authors:  G W Liddle
Journal:  Ann N Y Acad Sci       Date:  1966-11-22       Impact factor: 5.691

10.  Life-threatening hyperkalemia induced by arginine.

Authors:  D A Bushinsky; F J Gennari
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

View more
  8 in total

Review 1.  Pharmacologic Approaches to Electrolyte Abnormalities in Heart Failure.

Authors:  Justin L Grodin
Journal:  Curr Heart Fail Rep       Date:  2016-08

2.  Treatment of hypochloremia with acetazolamide in an advanced heart failure patient and importance of monitoring urinary electrolytes.

Authors:  Hajime Kataoka
Journal:  J Cardiol Cases       Date:  2017-11-10

Review 3.  Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.

Authors:  Jozine M ter Maaten; Mattia A E Valente; Kevin Damman; Hans L Hillege; Gerjan Navis; Adriaan A Voors
Journal:  Nat Rev Cardiol       Date:  2015-01-06       Impact factor: 32.419

Review 4.  Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.

Authors:  D A Sica; T W Gehr
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

5.  Acetazolamide as a potent chloride-regaining diuretic: short- and long-term effects, and its pharmacologic role under the 'chloride theory' for heart failure pathophysiology.

Authors:  Hajime Kataoka
Journal:  Heart Vessels       Date:  2019-05-21       Impact factor: 2.037

6.  Respiratory function and carbonic anhydrase inhibition.

Authors:  P G Berthelsen; J O Dich-Nielsen
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  Oxygen uptake and carbon dioxide elimination after acetazolamide in the critically ill.

Authors:  P Berthelsen; I Gøthgen; B Husum; E Jacobsen
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

8.  Role of diuretics and ultrafiltration in congestive heart failure.

Authors:  Dmitry Shchekochikhin; Fawaz Al Ammary; Jo Ann Lindenfeld; Robert Schrier
Journal:  Pharmaceuticals (Basel)       Date:  2013-07-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.